Locus-Conserved Circular RNA cZNF292 Controls Endothelial Cell Flow Responses.


Journal

Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103

Informations de publication

Date de publication:
07 01 2022
Historique:
pubmed: 19 11 2021
medline: 26 2 2022
entrez: 18 11 2021
Statut: ppublish

Résumé

Circular RNAs (circRNAs) are generated by back splicing of mostly mRNAs and are gaining increasing attention as a novel class of regulatory RNAs that control various cellular functions. However, their physiological roles and functional conservation in vivo are rarely addressed, given the inherent challenges of their genetic inactivation. Here, we aimed to identify locus conserved circRNAs in mice and humans, which can be genetically deleted due to retained intronic elements not contained in the mRNA host gene to eventually address functional conservation. Combining published endothelial RNA-sequencing data sets with circRNAs of the circATLAS databank, we identified locus-conserved circRNA retaining intronic elements between mice and humans. CRISPR/Cas9 mediated genetic depletion of the top expressed circRNA cZfp292 resulted in an altered endothelial morphology and aberrant flow alignment in the aorta in vivo. Consistently, depletion of cZNF292 in endothelial cells in vitro abolished laminar flow-induced alterations in cell orientation, paxillin localization and focal adhesion organization. Mechanistically, we identified the protein SDOS (syndesmos) to specifically interact with cZNF292 in endothelial cells by RNA-affinity purification and subsequent mass spectrometry analysis. Silencing of SDOS or its protein binding partner Syndecan-4, or mutation of the SDOS-cZNF292 binding site, prevented laminar flow-induced cytoskeletal reorganization thereby recapitulating cZfp292 knockout phenotypes. Together, our data reveal a hitherto unknown role of cZNF292/cZfp292 in endothelial flow responses, which influences endothelial shape.

Sections du résumé

BACKGROUND
Circular RNAs (circRNAs) are generated by back splicing of mostly mRNAs and are gaining increasing attention as a novel class of regulatory RNAs that control various cellular functions. However, their physiological roles and functional conservation in vivo are rarely addressed, given the inherent challenges of their genetic inactivation. Here, we aimed to identify locus conserved circRNAs in mice and humans, which can be genetically deleted due to retained intronic elements not contained in the mRNA host gene to eventually address functional conservation.
METHODS AND RESULTS
Combining published endothelial RNA-sequencing data sets with circRNAs of the circATLAS databank, we identified locus-conserved circRNA retaining intronic elements between mice and humans. CRISPR/Cas9 mediated genetic depletion of the top expressed circRNA cZfp292 resulted in an altered endothelial morphology and aberrant flow alignment in the aorta in vivo. Consistently, depletion of cZNF292 in endothelial cells in vitro abolished laminar flow-induced alterations in cell orientation, paxillin localization and focal adhesion organization. Mechanistically, we identified the protein SDOS (syndesmos) to specifically interact with cZNF292 in endothelial cells by RNA-affinity purification and subsequent mass spectrometry analysis. Silencing of SDOS or its protein binding partner Syndecan-4, or mutation of the SDOS-cZNF292 binding site, prevented laminar flow-induced cytoskeletal reorganization thereby recapitulating cZfp292 knockout phenotypes.
CONCLUSIONS
Together, our data reveal a hitherto unknown role of cZNF292/cZfp292 in endothelial flow responses, which influences endothelial shape.

Identifiants

pubmed: 34789007
doi: 10.1161/CIRCRESAHA.121.320029
doi:

Substances chimiques

DNA-Binding Proteins 0
Intracellular Signaling Peptides and Proteins 0
RNA, Circular 0
Syndecan-4 0
syndesmos protein, mouse 0
Transcription Factors 0
Zfp292 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

67-79

Auteurs

Andreas W Heumüller (AW)

Institute of Cardiovascular Regeneration (A.W.H., M.K., A.F., M.M.R., P.G., N.J., S.D.), Goethe University, Frankfurt, Germany.
Faculty for Biological Sciences (A.W.H.), Goethe University, Frankfurt, Germany.

Alisha N Jones (AN)

Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Germany (A.N.J., A.M., M.S.).
Biomolecular NMR and Center for Integrated Protein Science Munich at Department Chemie, Technical University of Munich, Garching, Germany (A.N.J., A.M., M.S.).

André Mourão (A)

Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Germany (A.N.J., A.M., M.S.).
Biomolecular NMR and Center for Integrated Protein Science Munich at Department Chemie, Technical University of Munich, Garching, Germany (A.N.J., A.M., M.S.).

Marius Klangwart (M)

Institute of Cardiovascular Regeneration (A.W.H., M.K., A.F., M.M.R., P.G., N.J., S.D.), Goethe University, Frankfurt, Germany.

Chenyue Shi (C)

Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (C.S., M.P., T.B.).

Ilka Wittig (I)

Functional Proteomics, Institute for Cardiovascular Physiology (I.W.), Goethe University, Frankfurt, Germany.
German Center for Cardiovascular Research (DZHK), Frankfurt, Germany (I.W., M.P., T.B., S.D.).

Ariane Fischer (A)

Institute of Cardiovascular Regeneration (A.W.H., M.K., A.F., M.M.R., P.G., N.J., S.D.), Goethe University, Frankfurt, Germany.

Marion Muhly-Reinholz (M)

Institute of Cardiovascular Regeneration (A.W.H., M.K., A.F., M.M.R., P.G., N.J., S.D.), Goethe University, Frankfurt, Germany.

Giulia K Buchmann (GK)

Institute for Cardiovascular Physiology (G.K.B.), Goethe University, Frankfurt, Germany.

Christoph Dieterich (C)

Institute of Cardiovascular Regeneration (A.W.H., M.K., A.F., M.M.R., P.G., N.J., S.D.), Goethe University, Frankfurt, Germany.
Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Germany (C.D.).

Michael Potente (M)

Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (C.S., M.P., T.B.).
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany (M.P.).
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany (M.P.).
German Center for Cardiovascular Research (DZHK), Frankfurt, Germany (I.W., M.P., T.B., S.D.).
Cardio-Pulmonary Institute (CPI), Frankfurt, Germany (M.P., T.B., S.D.).

Thomas Braun (T)

Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (C.S., M.P., T.B.).
German Center for Cardiovascular Research (DZHK), Frankfurt, Germany (I.W., M.P., T.B., S.D.).
Cardio-Pulmonary Institute (CPI), Frankfurt, Germany (M.P., T.B., S.D.).

Phillip Grote (P)

Institute of Cardiovascular Regeneration (A.W.H., M.K., A.F., M.M.R., P.G., N.J., S.D.), Goethe University, Frankfurt, Germany.

Nicolas Jaé (N)

Institute of Cardiovascular Regeneration (A.W.H., M.K., A.F., M.M.R., P.G., N.J., S.D.), Goethe University, Frankfurt, Germany.

Michael Sattler (M)

Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Germany (A.N.J., A.M., M.S.).
Biomolecular NMR and Center for Integrated Protein Science Munich at Department Chemie, Technical University of Munich, Garching, Germany (A.N.J., A.M., M.S.).

Stefanie Dimmeler (S)

Institute of Cardiovascular Regeneration (A.W.H., M.K., A.F., M.M.R., P.G., N.J., S.D.), Goethe University, Frankfurt, Germany.
Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (C.S., M.P., T.B.).
German Center for Cardiovascular Research (DZHK), Frankfurt, Germany (I.W., M.P., T.B., S.D.).
Cardio-Pulmonary Institute (CPI), Frankfurt, Germany (M.P., T.B., S.D.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH